Atara Biotherapeutics, Inc.
They are a leading T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.
Last Closing Price
January 4, 2018
J.P. Morgan, Cowen
To view the prospectus for Atara Biotherapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277